3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Cardiotoxicity
7
Neoplasms
3
Heart Failure
3
Breast Neoplasms
3
Cardiovascular Diseases
2
Ventricular Dysfunction, Left
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metabolic Syndrome
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Long QT Syndrome
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Diseases
1
Dyslipidemias
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Cardiomyopathies
1
Brugada Syndrome
1
Bone Marrow Diseases
1
Atrial Fibrillation
1
Arrhythmias, Cardiac
1
Interventions
Carboplatin
7
atezolizumab
3
Paclitaxel
3
apatinib
2
Pemetrexed
2
Erlotinib Hydrochloride
2
Bevacizumab
2
toripalimab
1
sintilimab
1
pegylated granulocyte colony-stimulating factor
1
durvalumab
1
cemiplimab
1
camrelizumab
1
Vinorelbine
1
Ultrasonography
1
Tyrosine Kinase Inhibitors
1
Telescopes
1
Sunitinib
1
Sodium Chloride
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Metformin
1
Magnetic Resonance Imaging
1
Kyphoplasty
1
Intubation
1
Injections, Epidural
1
Injections
1
Indocyanine Green
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thoracic Neoplasms
×
Electrocardiography
×
Clear all
NCT03396614
2024-02-28
CROSS SECT
University Medical Center Groningen
Completed
40 enrolled